Quick Answer
ONCOLYTICS BIOTECH INC reported Operating Income Loss of -$28.73 million for the year ending 2025.
- ONCOLYTICS BIOTECH INC showed a decrease of -12.5% in Operating Income Loss from 2024 to 2025.
- This data is from ONCOLYTICS BIOTECH INC's annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2024 to 2025 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Historical annual values: Fiscal year 2025: -$28.73 million | Fiscal year 2024: -$25.54 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: